Department of Radiation Oncology, New York University School of Medicine and Langone Medical Center, New York, New York 10016, USA.
Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):902-9. doi: 10.1016/j.ijrobp.2012.01.040. Epub 2012 Apr 9.
Damage to heart and lung from breast radiotherapy is associated with increased cardiovascular mortality and lung cancer development. We conducted a prospective study to evaluate which position is best to spare lung and heart from radiotherapy exposure.
One hundred consecutive Stage 0-IIA breast cancer patients consented to participate in a research trial that required two computed tomography simulation scans for planning both supine and prone positions. The optimal position was defined as that which best covered the contoured breast and tumor bed while it minimized critical organ irradiation, as quantified by the in-field heart and lung volume. The trial was designed to plan the first 100 patients in each position to study correlations between in-field volumes of organs at risk and dose.
Fifty-three left and 47 right breast cancer patients were consecutively accrued to the trial. In all patients, the prone position was optimal for sparing lung volume compared to the supine setup (mean lung volume reduction was 93.5 cc for right and 103.6 cc for left breast cancer patients). In 46/53 (87%) left breast cancer patients best treated prone, in-field heart volume was reduced by a mean of 12 cc and by 1.8 cc for the other 7/53 (13%) patients best treated supine. As predicted, supine-prone differences in in-field volume and mean dose of heart and lung were highly correlated (Spearman's correlation coefficient for left breast cancer patients was 0.90 for heart and 0.94 for lung and 0.92 for right breast cancer patients for lung).
Prone setup reduced the amount of irradiated lung in all patients and reduced the amount of heart volume irradiated in 87% of left breast cancer patients. In-field organ volume is a valid surrogate for predicting dose; the trial continued to the planned target of 400.
乳腺癌放疗引起的心、肺损伤与心血管死亡率增加和肺癌发展相关。我们进行了一项前瞻性研究,以评估哪种体位对放疗中肺和心脏的保护作用最佳。
连续纳入 100 例接受乳腺癌改良根治术的 0 期-ⅡA 期患者,参与一项需要两次计算机断层扫描模拟定位的研究,患者分别接受仰卧位和俯卧位定位。最佳体位是指既能最大限度地覆盖靶区和肿瘤床,又能最小化关键器官照射剂量的体位,这通过计算靶区内心脏和肺的受照体积来量化。该试验旨在为每个体位的前 100 例患者制定计划,以研究危险器官受照体积和剂量之间的相关性。
连续纳入了 53 例左侧乳腺癌和 47 例右侧乳腺癌患者。在所有患者中,俯卧位与仰卧位相比,更有利于保护肺体积(右侧和左侧乳腺癌患者的平均肺体积减少分别为 93.5cc 和 103.6cc)。在 46/53 例(87%)左侧乳腺癌患者中,俯卧位为最佳体位,靶区内心脏体积平均减少 12cc,而在其余 7/53 例(13%)最佳体位为仰卧位的患者中,靶区内心脏体积减少 1.8cc。正如预期的那样,左侧乳腺癌患者仰卧位-俯卧位的靶区内体积和心脏、肺的平均剂量差异具有高度相关性(Spearman 相关系数分别为 0.90 用于心脏,0.94 用于肺,0.92 用于右侧乳腺癌患者的肺)。
俯卧位可减少所有患者的照射肺体积,减少 87%的左侧乳腺癌患者的心脏受照体积。靶区内器官体积是预测剂量的有效替代指标;该试验继续按计划目标 400 例进行。